Zacks Investment Research on MSN4d
GSK Stock Recovers, Rises Around 17% YTD: Time to Buy, Sell or Hold?
GSK GSK stock has risen 16.9% year to date compared with an increase of 7.0% for the industry. The stock has also ...
Zacks.com on MSN4d
Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B
Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...
Pfizer to sell entire Haleon stake
Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.
Pfizer Sells Final Haleon Shares for $3.2B, Ends Stake in Consumer Healthcare Giant
Pfizer has finalized the sale of its entire holding in Haleon , generating approximately 2.5 billion ($3.24 billion), Reuters ...
European Medical Journal5d
Pfizer completes exit from Haleon
Pfizer has announced plans to sell its remaining stake in Haleon plc, divesting approximately 662 million shares.
Fierce Pharma5d
Pfizer pockets roughly £2.5B as it shaves off final stake in consumer health spinoff Haleon
With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. | After charting similar moves ...
Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion
Pfizer sold its entire 7.3% shareholding in London-listed consumer-health company Haleon for a net sum of 2.5 billion pounds ($3.25 billion). Pfizer sold 618 million shares for 385 pence each. The ...
Pfizer exits Haleon stake after $3.2B share sale
Pfizer (PFE) stock in focus as the company sells its entire 7.3% stake in Haleon (HLN) for $3.24B. Read more here.